Alta Partners Management Company, L.P. Allakos Inc. Transaction History

Alta Partners Management Company, L.P.

  • $41.6 Billion
  • Q2 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
BUY
$0.62 - $1.5 $1.58 Million - $3.82 Million
2,546,147 New
2,546,147 $3.08 Billion

Others Institutions Holding ALLK

# of Institutions
3
Shares Held
1.29M
Call Options Held
0
Put Options Held
0
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $28M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Alta Partners Management Company, L.P. Portfolio

Follow Alta Partners Management Company, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Partners Management Company, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alta Partners Management Company, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email